Regencell Bioscience Holdings Ltd (RGC) stock
RGCNasdaqMedicinal Chemicals & Botanical Products
$4.69+0.14 (+3.08%)
Close on Nov 18, 2026Market cap $2.33BP/E –Yield –
Regencell Bioscience market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Regencell Bioscience's market cap was $2.68B on Nov 11, 2026, against $5.70B a year earlier. Over the last 5 years it ranged from $43.71M to $14.45B, with a median of $350.02M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.68B | -74.2% |
| 2025 | Dec 31, 2025 | $10.38B | +16053.8% |
| 2024 | Dec 31, 2024 | $64.28M | -52.9% |
| 2023 | Dec 29, 2023 | $136.63M | -62.4% |
| 2022 | Dec 30, 2022 | $362.91M | +13.9% |
| 2021 | Dec 31, 2021 | $318.52M | – |
See a number that looks wrong?